U.S. Stock News

Tariffs on Canadian dairy, alcohol, and autos are reshaping expectations for cross border trade, and that puts the spotlight on U.S. Domestic Manufacturing stocks with direct or indirect exposure to this news. The new 50% tariffs and the risk of retaliation could shift where goods are produced, how supply chains are structured, and which companies gain or lose pricing power. This article looks at three stocks from the U.S. Domestic Manufacturing screener that appear to be positively exposed...

Earlier this year, MCBANK announced it had selected Jack Henry & Associates’ modern core processing platform, Banno Digital Platform, treasury management tools, and Managed Secure Cloud to support its commercial and retail banking operations. This client win ties Jack Henry’s technology directly to MCBANK’s capital-backed plan to expand into a larger regional commercial and private bank through organic growth and acquisitions. We’ll now examine how securing MCBANK’s core and digital banking...

Elevance Health (ELV) has drawn investor attention after updating its connected cancer care model. The updated approach now relies more on predictive analytics, oncology navigators, and digital tools to support patients and coordinate care delivery. See our latest analysis for Elevance Health. Over the past year Elevance Health has combined product updates such as the refreshed cancer care model with a steady share price trend, delivering a 1 year total shareholder return of 39.71% alongside...

In the past week, Stanley Black & Decker reported second-quarter 2026 results showing sales of US$3,960.7 million and net income of US$351.3 million, alongside a higher full‑year GAAP EPS outlook of US$4.60 to US$5.45, a US$250 million share buyback completion, and a quarterly dividend increase to US$0.84 per share. Together, stronger profitability, raised earnings guidance, capital returns via buybacks and a dividend lift highlight management’s confidence in the business while compressing...

Brighthouse Financial (BHF) has drawn investor attention after recent share price moves that include declines of about 2% over the past week and 3% over the past month, alongside a 34.1% total return over the past year. See our latest analysis for Brighthouse Financial. The recent 1 day share price decline of about 2.4% to US$61.91 follows several weeks of softer momentum, even though Brighthouse Financial’s 1 year total shareholder return of roughly 34% remains strongly positive. If this mix...

In July 2026, Las Vegas Sands Corp. reported second-quarter 2026 results showing slightly lower quarterly sales and net income year on year, alongside stronger six-month revenue and earnings, while also affirming a quarterly dividend of US$0.30 per share. At the same time, the company completed a long-running US$8.07 billion buyback program and increased its remaining repurchase authorization to US$6.00 billion through 2029, highlighting an ongoing commitment to returning capital to...

Builders FirstSource (BLDR) is back in focus after second quarter 2026 results showed weaker housing demand, tighter pricing, and a swing to a small net loss, along with a reduced full-year outlook. See our latest analysis for Builders FirstSource. The recent quarterly loss and reduced outlook appear reflected in Builders FirstSource’s weaker momentum. The share price is down 21.62% over 30 days and the 1-year total shareholder return is down 48.96%, despite a positive 5-year total...

Community Financial System (CBU) has drawn fresh investor attention after releasing second quarter 2026 results, reporting net income of US$61.33 million, lower net charge offs, updated buyback activity, and a new quarterly dividend declaration. See our latest analysis for Community Financial System. Community Financial System's recent earnings, buyback activity, and dividend increase come against a share price of US$64.81 that is modestly lower over the past month yet still ahead year to...

In July 2026, Live Oak Bancshares, Inc. reported second-quarter 2026 results showing net interest income of US$125.34 million and net income of US$36.8 million, both higher than the same period a year earlier, with basic earnings per share from continuing operations rising to US$0.75. Alongside this earnings strength, the bank’s net charge-offs fell to US$24,162,000 from US$31,445,000 a year before, highlighting an improvement in credit costs that could be particularly important for a...

XTransfer, a leading B2B cross-border trade payment platform, has been named to CNBC's 2026 list of the World's Top Fintech Companies in the Payments Segment, highlighting its growing impact in the digital payments landscape. This recognition underscores the company's commitment to providing secure and efficient cross-border payment solutions for SMEs, thereby addressing the complexities of international financial operations. XTransfer's inclusion in this prestigious list, compiled with...

BJ's Restaurants (BJRI) stock was in focus after Q2 2026 results showed sales of $388.89 million and adjusted EPS of $0.94, with management highlighting commodity cost pressures and expectations for margin improvement ahead. See our latest analysis for BJ's Restaurants. Despite a sharp 8.96% decline in the latest 1 day share price return, BJ's Restaurants stock has shown strong recent momentum, with a 30 day share price return of 11.40% and a 1 year total shareholder return of 97.86%,...

The latest Federal Reserve meeting kept interest rates on hold but still triggered the Dow’s worst single-session drop in over a year and exposed rare internal division at the FOMC. With inflation at 4.2% and pressure building on long-term Treasury yields, many investors are reassessing how much risk they want to carry in rate sensitive areas of the market. This article looks at three dividend paying stocks from our Defensive Dividend Stocks screener that appear closely tied to these cross...

Renewed interest in MKS (MKSI) as a supplier to AI focused semiconductor equipment and complex circuit boards has pushed the stock sharply higher, with investors debating whether the recent move reflects perceived undervaluation. See our latest analysis for MKS. Recent trading in MKS reflects a mixed picture, with the share price down 27.64% over the past 30 days but still showing strong momentum over longer periods. This includes a 76.68% year to date share price return and a 222.42% total...

Newmark Group, Inc. reported its second-quarter 2026 results, showing higher sales and revenue year over year, while net income and earnings per share from continuing operations were broadly stable, alongside continued share repurchases and a reaffirmed quarterly dividend of US$0.0600 per share. An interesting takeaway is that, despite only modest quarterly net income movement, Newmark has now repurchased over half of its shares originally authorized under the long-running buyback program,...

Recent performance snapshot for Navigator Holdings Navigator Holdings (NYSE:NVGS) has drawn investor attention after a period of strong share price performance, with the stock up 20.0% over the past month and 2.1% over the past 3 months. The company, which owns and operates 57 liquefied gas carriers, last closed at US$22.35, giving it a market value of about US$1.37b based on the latest available data. See our latest analysis for Navigator Holdings. The recent 20.0% 1 month share price return...

Euronet Worldwide earnings and buyback activity in focus Euronet Worldwide (EEFT) reported second quarter 2026 results that combined higher sales with lower profitability, while also updating investors on progress under its multi year share repurchase program. Sales for the quarter reached US$1,108.4 million compared with US$1,074.3 million a year earlier. Net income was US$77.4 million versus US$97.6 million, with diluted earnings per share from continuing operations at US$1.71 compared with...

The latest merger speculation swirling around AstraZeneca and Bristol Myers Squibb has pushed large cap pharma stocks back into the spotlight. Sharp price moves, including AstraZeneca’s intraday fall of up to 7% and a 6% premarket jump for Bristol Myers, show how quickly sentiment can shift when potential mega deals hit the headlines. For investors, this kind of disruption can surface both opportunities and risks. This article looks at 3 stocks from a Healthcare screener that are exposed to...

Antero Midstream Corporation recently reported its second-quarter 2026 results, with revenue rising to US$327.24 million while net income eased to US$113.52 million, alongside record adjusted EBITDA and gathering volumes above 4.1 Bcf per day. The company also received over US$370 million in damages and interest, lowering pro forma leverage to 2.8 times and supporting major pipeline expansion plans, including the East Side Express project. We’ll now examine how the damages-driven leverage...

Regeneron Pharmaceuticals (REGN) is back in focus after reporting second quarter 2026 results that showed revenue of US$4.29b, alongside a quarterly dividend declaration and a new radiopharmaceuticals collaboration with Telix Pharmaceuticals. See our latest analysis for Regeneron Pharmaceuticals. At a share price of US$762.63, Regeneron Pharmaceuticals has seen a 30 day share price return of 22.08% and a 1 year total shareholder return of 37.21%. This points to building momentum following...

Autohome (NYSE:ATHM) has announced a new share repurchase program of up to US$400 million. The program has been authorized by its Board and is set to run for 12 months, funded entirely from existing cash reserves. See our latest analysis for Autohome. The buyback news lands after a strong short term share price run for Autohome, with a 7 day share price return of 10.0% and a 30 day return of 21.63% helping to lift the 90 day share price return to 24.84%. However, the 1 year total shareholder...

Cullinan Therapeutics reported that it previously received positive feedback from the U.S. FDA following an End-of-Phase 1 meeting for CLN-049, clearing the way for a potentially registrational Phase 2 trial in relapsed/refractory acute myeloid leukemia and additional combination studies in previously untreated patients. The FDA’s alignment on a seamless Phase 2 design and CLN-049’s Fast Track and Orphan Drug designations together underscore the program’s regulatory momentum in a...

The United States market remained flat over the last week but has shown an impressive 18% rise over the past 12 months, with earnings forecasted to grow by 16% annually. In this context, identifying stocks that are potentially undervalued can be crucial for investors seeking opportunities in a dynamic market environment.

In the last week, the United States market has remained flat, yet it has risen by 18% over the past year with anticipated earnings growth of 16% per annum in the coming years. In this environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation.

Palomino Laboratories has completed its acquisition of Vega Links, positioning itself as a key player in the next-generation AI interconnect field. This strategic move significantly expands Palomino's addressable market to over $60 billion and accelerates its capabilities in AI infrastructure. With the integration of Vega Links’ expertise in high-speed AI and memory connectivity, Palomino aims to enhance AI interconnect technologies that improve bandwidth, latency, and power efficiency...